ALEXANDRA KORDA

Dr. ALEXANDRA KORDA


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
MAMihai Avram
Mihai Avram
LFLydia Fortea
Lydia Fortea
LWLea Wollner
Lea Wollner
RCRicarda Coenen
Ricarda Coenen
AKALEXANDRA KORDA
ALEXANDRA KORDA
SBStefan Borgwardt
Stefan Borgwardt
Psychedelics have recently attracted significant attention for their potential to mitigate symptoms associated with various psychiatric disorders. However, the precise neurobiological mechanisms responsible for these effects remain incompletely understood. A valuable approach to gaining insights into the specific mechanisms of action involves comparing psychedelics with substances that have partially overlapping neurophysiological effects, i.e., modulating the same neurotransmitter systems. Imaging data were obtained from the clinical trial NCT03019822, which explored the acute effects of lysergic acid diethylamide (LSD), d-amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in 28 healthy volunteers. The clinical trial employed a double-blind, placebo-controlled, crossover design. Herein, various resting-state connectivity measures were examined, including within-network connectivity (integrity), between-network connectivity (segregation), seed-based connectivity of resting-state networks, and global connectivity. Differences between placebo and the active conditions were assessed using repeated-measures ANOVA, followed by post-hoc pairwise t-tests. Changes in voxel-wise seed-based connectivity were correlated with serotonin 2 A receptor density maps. Compared to placebo, all substances reduced integrity in several networks, indicating both common and unique effects. While LSD uniquely reduced integrity in the default-mode network (DMN), the amphetamines, in contrast to our expectations, reduced integrity in more networks than LSD. However, LSD exhibited more pronounced segregation effects, characterized solely by decreases, in contrast to the amphetamines, which also induced increases. Across all substances, seed-based connectivity mostly increased between networks, with LSD demonstrating more pronounced effects than both amphetamines. Finally, while all substances decreased global connectivity in visual areas, compared to placebo, LSD specifically increased global connectivity in the basal ganglia and thalamus. These findings advance our understanding of the distinctive neurobiological effects of psychedelics, prompting further exploration of their therapeutic potential.

16 May 2021 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
AKALEXANDRA KORDA
ALEXANDRA KORDA
ARA. Ruef
A. Ruef
SNS. Neufang
S. Neufang
CDC. Davatzikos
C. Davatzikos
SBS. Borgwardt
S. Borgwardt
NKN. Koutsouleris
N. Koutsouleris

25 April 2022 in Clinical Neurophysiology
Verified
Journal Article
Closed access
AKALEXANDRA KORDA
ALEXANDRA KORDA
EVE. Ventouras
E. Ventouras
PAP. Asvestas
P. Asvestas
MTMaida Toumaian
Maida Toumaian
GMG.K. Matsopoulos
G.K. Matsopoulos
NSN. Smyrnis
N. Smyrnis

16 November 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
AKALEXANDRA KORDA
ALEXANDRA KORDA
CAChristina Andreou
Christina Andreou
HRHelena Victoria Rogg
Helena Victoria Rogg
MAMihai Avram
Mihai Avram
ARAnne Ruef
Anne Ruef
SBStefan Borgwardt
Stefan Borgwardt
Structural MRI studies in first-episode psychosis and the clinical high-risk state have consistently shown volumetric abnormalities. Aim of the present study was to introduce radiomics texture features in identification of psychosis. Radiomics texture features describe the interrelationship between voxel intensities across multiple spatial scales capturing the hidden information of underlying disease dynamics in addition to volumetric changes. Structural MR images were acquired from 77 first-episode psychosis (FEP) patients, 58 clinical high-risk subjects with no later transition to psychosis (CHR_NT), 15 clinical high-risk subjects with later transition (CHR_T), and 44 healthy controls (HC). Radiomics texture features were extracted from non-segmented images, and two-classification schemas were performed for the identification of FEP vs. HC and FEP vs. CHR_NT. The group of CHR_T was used as external validation in both schemas. The classification of a subject’s clinical status was predicted by importing separately (a) the difference of entropy feature map and (b) the contrast feature map, resulting in classification balanced accuracy above 72% in both analyses. The proposed framework enhances the classification decision for FEP, CHR_NT, and HC subjects, verifies diagnosis-relevant features and may potentially contribute to identification of structural biomarkers for psychosis, beyond and above volumetric brain changes.

17 November 2024 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
Giorgos GiannakakisGiorgos Giannakakis
Giorgos Giannakakis
ARAnastasios Roussos
Anastasios Roussos
CAChristina Andreou
Christina Andreou
SBStefan Borgwardt
Stefan Borgwardt
AKALEXANDRA KORDA
ALEXANDRA KORDA

2 January 2024 in Nature Mental Health
Verified
Journal Article
Open access
PDF file
AKALEXANDRA KORDA
ALEXANDRA KORDA
CAChristina Andreou
Christina Andreou
ARAnne Ruef
Anne Ruef
LHLisa Hahn
Lisa Hahn
ASAndré Schmidt
André Schmidt
TCthe PRONIA Consortium
the PRONIA Consortium
The inter-relationships of voxels can be captured by the radiomics texture features across multiple spatial scales. Prediction models of brain texture changes captured by the contrast texture feature in recent-onset psychosis (ROP) and recent-onset depression (ROD) have recently been proposed, although the validation of these models transdiagnostically at the individual level and the investigation of the variability in clinical profiles are lacking. Established prevention and treatment approaches focus on specific diagnoses and do not address the heterogeneity and manifold potential outcomes of patients. Here we aimed to investigate the cross-sectional utility of brain texture changes for (1) identification of the psychopathological state (ROP and ROD) and (2) the association of individualized brain texture maps with clinical symptom severity and outcome profiles. We developed transdiagnostic models based on structural magnetic resonance imaging data for 116 patients with ROD, 122 patients with ROP and 197 healthy control participants from the PRONIA (Personalized pROgNostic tools for early psychosIs mAnagement) study by applying a set of tools and frameworks to explain the classification decisions of the deep-learning algorithm (named explainable artificial intelligence) and clustering analysis. We investigated the contrast texture feature as the key feature for the identification of a general psychopathological state. The discrimination power of the trained prediction model was >72% and was validated in a second independent age- and sex-matched sample of 137 ROP, 94 ROD and 159 healthy control participants. Clustering analysis was implemented to map the changes in texture brain produced from an explainable artificial intelligence algorithm, in a group fashion. The explained individualized brain contrast map grouped into eight homogeneous clusters. In the clinical group, we investigated the association between the explained brain contrast texture map and clinical symptom severity as well as outcome profiles. Different patterns in the explained brain contrast texture map showed unique associations of brain alterations with clinical symptom severity and clinical outcomes, that is, age, positive, negative and depressive symptoms, and functionality. In some clusters, the mean explained brain contrast texture map values and/or brain contrast texture voxels that contributed significantly to the classification decision predicted accurately the PANSS (positive and negative symptom scale) scores, functionality and change in functionality over time. In conclusion, we created homogeneous clusters which predict the clinical severity and outcome profile in ROP and ROD patients.